Seeking Alpha

Alnylam Pharmaceuticals (ALNY) says the Court has ruled in its favor and denied Tekmira...

Alnylam Pharmaceuticals (ALNY) says the Court has ruled in its favor and denied Tekmira Pharmaceuticals' motion to disqualify ALNY's counsel in an infringement suit ALNY filed in January. The suit is based upon allegations that Tekmira improperly provided lipid nanoparticle-formulated small interfering RNA molecules to pharmaceutical collaborators. In addition, ALNY says it's expanded the infringement action with a suit in Canada.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector